Takeda Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Takeda Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Takeda Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Takeda Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Takeda Pharmaceutical Co Ltd (Takeda) develops, manufactures, sells, markets, imports and exports ethical pharmaceutical drugs for various conditions, with special focus on neuroscience, rare diseases, gastrointestinal, plasma-derived therapies and oncology. Takeda markets in-house drugs in several countries across the world. It also develops vaccines for addressing critical public health threats using novel development platforms. Takeda manufactures medicines for patients on three platforms, namely, Small Molecules and Vaccines, Biologics, Plasma Derived Therapies. The company operates in product categories such as Oncology, Rare Genetics, Gastroenterology, Rare Hematology, PDT Immunology, Neuroscience, and Others.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Takeda has launched multiple R&D initiatives, centered on converting science into highly innovative, life-changing medicines. The company’s R&D engine concentrates on three areas: Innovative Biopharma, Plasma-Derived Therapies, and Vaccines. Its R&D work has generated new molecular entities that may become best-in-class and/or first-in-class medicines addressing significant unmet medical needs. Takeda is also investing in cell and gene therapies and adopting data and digital technologies to enhance innovation quality and speed execution. The R&D team collaborates closely with commercial functions to maximize the value of marketed products and incorporate commercial insights into R&D strategies and the portfolio. External collaborations with third-party partners are a vital element of Takeda’s approach to strengthening its R&D pipeline. Takeda’s R&D units include Innovative Biopharma, Plasma-Derived Therapies, and Vaccines. Innovative Biopharma is the largest share of R&D investment and has delivered promising new molecular entities. Plasma-Derived Therapies concentrates on developing therapies sourced from plasma. The Vaccines unit focuses on developing vaccines for diverse diseases. The company’s R&D efforts target therapeutic areas including oncology, rare genetics & hematology, neuroscience, and gastrointestinal and inflammation. In FY2026, the company spent JPY668,565 million on its R&D activities, which as a percentage of revenue stood at 14.8%. The company operates R&D facilities in Vienna, Austria; San Diego, California, and Cambridge, Massachusetts, the US; and Shonan, Japan.
Product Categories
- Digestive System Diseases
- Neuroscience
- Oncology
- Others
- Plasma derived products
- Rare Diseases
- Vaccines
Overview
Offer therapies for patients with inflammatory bowel disease, acid-related diseases, motility disorders and liver diseases. - Major products include Entyvio for moderate to severe ulcerative colitis; Dexilant for gastroesophageal reflux disease; Pantoprazole and Takecab-F for gastroesophageal reflux disease; and Amitiza for opioid-induced constipation, chronic idiopathic constipation and women with irritable bowel syndrome with constipation.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products for patients with neurological diseases, including major depressive disorder, attention-deficit hyperactivity disorder and binge eating disorder. - Major products include Trintellix, an antidepressant used for the treatment of major depressive disorder in adults; Vyvanse, a stimulant medication used for the treatment of attention deficit hyperactivity disorder (ADHD); and Adderall XR for ADHD.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides medicines to patients with cancer across the world. - Major products include Ninlaro for multiple myeloma; Velcade for multiple myeloma and mantle cell lymphoma; Alunbrig for non-small cell lung cancer; and Iclusig for chronic myeloid leukemia.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers plasma derived therapies for immune deficiency diseases. - Major products include Albumin used for hypovolemia and hypoalbuminemia, and Immunoglobulin for primary immunodeficiency and multifocal motor neuropathy.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Focuses on therapies for life-threatening, low-prevalence conditions. - Major products include Takhzyro for hereditary angioedema; Livtencity for refractory post-transplant CMV; Adzynma (rADAMTS13) for congenital TTP; Elaprase for Hunter syndrome (MPS II); Replagal for Fabry disease; and Advate for hemophilia A.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers Qdenga, a live-attenuated tetravalent dengue vaccine using a serotype 2 backbone to protect against all four dengue serotypes. It is available in 29 countries across endemic and travel markets.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
- Asia (excluding Japan & China)
- Central and South America
- China
- Europe and Canada
- Japan
- Other
- Russia/CIS
- United States
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer